These 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts
Past performance may not guarantee future results, but it can still provide valuable clues. When a stock suddenly breaks higher on unusually strong...
Replimune Group Inc. (REPL)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 11,045,336 | $122,271,870 | 0.61% | |
| 2. | Ridgeback Capital Management Wayne Holman | 7,310,656 | $80,928,962 | 100% | |
| 3. | Suvretta Capital Management Aaron Cowen | 4,389,836 | $48,595,485 | +4% | 0.89% |
| 4. | Boxer Capital Aaron Davis And Christopher Fuglesang | 3,983,000 | $44,091,810 | +239% | 3.32% |
| 5. | AQR Capital Management Cliff Asness | 2,566,241 | $28,408,287 | +905% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.61 | 1,100,000 | $14,971,000.00 | 1,100,000 | 2019-11-18 | Filing | |
| $13.61 | 220,000 | $2,994,200.00 | 5,328,939 | 2019-11-18 | Filing | |
| $15.00 | 133,333 | $1,999,995.00 | 4,721,449 | 2018-07-24 | Filing | |
| $15.00 | 6,667 | $100,005.00 | 6,667 | 2018-07-24 | Filing | |
| $15.00 | 133,333 | $1,999,995.00 | 4,721,449 | 2018-07-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.28 | 9,256 | $132,175.68 | 215,852 | 2026-08-17 | Filing | |
| $12.97 | 39,341 | $510,252.77 | 708,151 | 2026-08-10 | Filing | |
| $12.97 | 11,448 | $148,480.56 | 225,108 | 2026-08-10 | Filing | |
| $12.97 | 11,447 | $148,467.59 | 224,215 | 2026-08-10 | Filing | |
| $12.97 | 7,632 | $98,987.04 | 99,425 | 2026-08-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,958,535 | $99,170,982 | 0% | |
| 2. | 7,411,581 | $82,046,202 | 0.7% | |
| 3. | 4,541,018 | $50,269,070 | 0% | |
| 4. | 4,440,144 | $49,152,394 | 0% | |
| 5. | 2,952,800 | $32,687,496 | 0.15% |
News See All
Why Is Replimune (REPL) Stock Up Today?
Replimune stock rallied on Friday thanks to an FDA update that acted as a catalyst for analyst upgrades.
Why is Biotech Stock Replimune (REPL) Soaring Over 120% Today?
Shares in biotechnology company Replimune ($REPL) soared over 120% in pre-market trading today after U.S. regulators gave the thumbs up to its skin...
Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision
We recently compiled a list of the 10 Best Biotech Stocks Under $10 to Buy. Replimune Group, Inc. is among the best biotech stocks to invest in.
10 Best Biotech Stocks Under $10 to Buy
In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy.
Replimune Group (REPL) Nosedives 39% as FDA Approval for Melanoma Treatment 'Uncertain'
We recently published 10 Stocks Losing Big Amid Market Boom. Replimune Group, Inc. (NASDAQ:REPL) is one of the worst performers on Thursday.
Replimune Group, Inc. (NASDAQ:REPL) Q4 2025 Earnings Call Transcript
Replimune Group, Inc. (NASDAQ:REPL) Q4 2025 Earnings Call Transcript May 22, 2025Replimune Group, Inc. misses on earnings expectations. Reported EPS is $-0.82 EPS, expectations were $-0.75.
12 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 12 best medical stocks to buy under $10.
15 Small-Cap Stocks with High Potential
In this article, we will take a look at the 15 small-cap stocks with high potential.
12 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 12 stocks with biggest upside potential according to analysts. The stock market has been in constant turmoil during the last few years.
Hedge Fund Resource Center